Difficulty: Medium
Average Score: 86%
Practice
Indication for pamidronate administration is:
Correct answer
D
Rationale
In the context of safety pharmacology across the lifespan, the indication for pamidronate administration is primarily for the treatment of hypercalcemia. Pamidronate is a bisphosphonate drug that works by inhibiting bone resorption, thus reducing elevated levels of calcium in conditions such as hypercalcemia.
Option A, failure of vitamin D formation in the skin, is incorrect because pamidronate is not indicated for vitamin D deficiencies. Option B, hypoparathyroidism, is also incorrect as pamidronate is not primarily used to manage this condition. Option C, elevated skeletal turnover, is not the main indication for pamidronate; although it can help reduce skeletal turnover, its primary use is in addressing hypercalcemia.
In an educational context, understanding the correct indication for pamidronate is crucial for healthcare professionals involved in the management of patients with hypercalcemia, such as those with certain cancers or hyperparathyroidism. This knowledge ensures appropriate and effective pharmacological interventions to maintain patient safety and well-being.
Option A, failure of vitamin D formation in the skin, is incorrect because pamidronate is not indicated for vitamin D deficiencies. Option B, hypoparathyroidism, is also incorrect as pamidronate is not primarily used to manage this condition. Option C, elevated skeletal turnover, is not the main indication for pamidronate; although it can help reduce skeletal turnover, its primary use is in addressing hypercalcemia.
In an educational context, understanding the correct indication for pamidronate is crucial for healthcare professionals involved in the management of patients with hypercalcemia, such as those with certain cancers or hyperparathyroidism. This knowledge ensures appropriate and effective pharmacological interventions to maintain patient safety and well-being.